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Oxidation of monoclonal antibodies (mAbs) is one of the major product quality issues with potential impacts on 
product activity and immunogenicity. Tryptophan oxidation (Trp-ox) leads to addition of one or two oxygen 
atoms to the indole ring of its side chain and other subsequent degradation end products. It was reported that 
Trp-ox in the complementarity-determining region of a mAb led to a progressive loss of antigen binding and 
biological activity 1. Trp-ox was also reported to cause color changes in near UV−visible light-irradiated and 
heat-stressed monoclonal antibody (mAb) drug product in liquid formulation 2. In addition, Trp-ox was observed 
under real-time storage and elevated temperature conditions 3. Recently, we observed that modifying the 
concentrations of copper, manganese, tryptophan, and cysteine in cell culture media/feed had a significant 
impact on Trp-ox levels of two mAbs in development produced in Chinese hamster ovary (CHO) cells 4. We 
have demonstrated that Trp-ox level can be effectively controlled while maintaining productivity and overall 
suitable product quality profiles. In this presentation we will summarize those findings and the results from the 
systematic studies that enabled us to control the Trp-ox levels at both the shake flask and benchtop bioreactor 
scales. Moreover, we will describe new studies that aimed to understand the potential mechanism of action 
(MOA) of those components on controlling Trp-ox levels.  
 
The advent of NGS technologies and the availability of CHO reference genomes have enabled the systematic 
analysis of CHO biology and its capacity for recombinant protein production 5, 6. Here we applied transcriptomic 
analysis using RNA-Seq to explore the underlying mechanisms of cell culture’s impact on Trp-ox. Cell samples 
from fed-batch bioreactors cultured with control or modified media/feed were harvested and subjected to RNA-
Seq analysis. The results showed that cell culture conditions had little impact on the expression of the mAb 
transgenes (LC and HC), nor genes related to glycosylation, which is consistent with the previous findings on 
mAb productivity and glycosylation profile 4. However, cell culture conditions did significantly alter the expression 
of multiple genes (fold change ≥1.5, p-value 0.05). Specific subsets of genes involved in control of oxidative 
stress and metabolism of copper, manganese, tryptophan cysteine will be discussed in detail. The analyses will 
focus on genes engaged in scavenging of free radicals because of their known roles in oxidation chemistry and 
production of reactive oxygen species (ROS). We postulate that these changes in gene expression may provide 
molecular means to balance the copper availability and glutathione pool, which in turn might result in the 
observed impact on mAb quality without changing the CHO cell growth and productivity. The work presented 
here provide another example of how gene expression analyses can shed additional light on potential 
mechanisms for observed cell culture performance and specifically in this case, changes in recombinant protein 
product quality attributes. Such understanding could eventually lead to a biomarker-based approach for process 
optimizations. To the best of our knowledge, this is the first example of using transcriptomic analysis to 
mechanistically understand the impact of cell culture on critical quality attributes other than glycosylation. 
Therefore, we believe this presentation is of great interest to general biopharmaceutical community and is 
relevant the themes of the Conference, especially to the section “Advances in cell culture control of product 
quality attributes”.  
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